Soares, Luciane A. http://orcid.org/0000-0002-7769-9396
Nascimento, Laura M. M. http://orcid.org/0000-0002-8578-7273
Guimarães, Francisco S. http://orcid.org/0000-0003-4092-7778
Gazarini, Lucas http://orcid.org/0000-0003-4771-4871
Bertoglio, Leandro J. http://orcid.org/0000-0003-2876-1146
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (304851/2022-1)
Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/24304-0)
Article History
Received: 11 January 2024
Accepted: 19 April 2024
First Online: 1 May 2024
Declarations
:
: Francisco S. Guimarães is a co-inventor (Mechoulam R, JC, Guimaraes FS, AZ, JH, Breuer A) of the patent "Fluorinated CBD compounds, compositions and uses. Pub. No.: WO/2014/108899. International Application No.: PCT/IL2014/050023" Def. US no. Reg. 62193296; 29/07/2015; INPI on 19/08/2015 (BR1120150164927). The University of São Paulo has licensed the patent to Phytecs Pharm (USP Resolution No. 15.1.130002.1.1). The University of São Paulo has an agreement with Prati-Donaduzzi (Toledo, Brazil) to "develop a pharmaceutical product containing synthetic cannabidiol and prove its safety and therapeutic efficacy in the treatment of epilepsy, schizophrenia, Parkinson's disease, and anxiety disorders". The other authors declare no competing interests.